Allstate Corporation’s Nuvalent NUVL Stock Holding History

Allstate Corporation’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$698K	Buy	5,655 +136	+2%	+$14.6K	0.01%	892
2026 Q1	$565K	Buy	+5,519	New	+$562K	0.01%	982

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Allstate Corporation's NUVL Position: Q2 2026 in Review

Allstate Corporation increased its Nuvalent (NUVL) stake by 2.5% in Q2 2026, buying an estimated $14.6K and bringing the position to 5,655 shares worth $698K. The position accounts for 0.01% of the portfolio, ranked #892.

Allstate Corporation first reported a position in NUVL in Q1 2026 and has held it in 2 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Allstate Corporation held 5,655 shares of Nuvalent worth $698K as of Q2 2026.
Allstate Corporation bought 136 Nuvalent shares in Q2 2026, an estimated $14.6K.
Nuvalent made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #892 holding.
Allstate Corporation first reported a position in Nuvalent in Q1 2026 and has held it in 2 quarters since.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.